Center Laboratories, Inc. (TPEX: 4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
41.50
-0.40 (-0.95%)
Dec 20, 2024, 1:30 PM CST
-7.37%
Market Cap 29.90B
Revenue (ttm) 1.57B
Net Income (ttm) -415.44M
Shares Out 720.42M
EPS (ttm) -0.60
PE Ratio n/a
Forward PE n/a
Dividend 1.50 (3.61%)
Ex-Dividend Date Aug 2, 2024
Volume 1,255,586
Open 42.20
Previous Close 41.90
Day's Range 41.50 - 42.20
52-Week Range 40.10 - 59.60
Beta 0.82
Analysts n/a
Price Target n/a
Earnings Date Mar 25, 2025

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising of antipyretic and analgesic, bronchodilator, anti-inflammatory preparations, anti-allergic agent, expectorant, narcotic antitussive and expectorant, gastrointestinal preparations, non-narcotic antitussive and expectorant, and other medicines. It also offers central nervous system medication consisting of cerebrovascular disease, dementia, depressi... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.